Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gene therapy -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (232)	9/5/2000 4:37:58 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 319

Yikes--talk about selective memory, I actually sold tons of warrants after only a double or triple...so I was selling, just as Scott was buying! average ARIAW purchase price was $0.75 - $1.00 Message 14318927 So that goes to show--when you make a sale, think about the fact that there is a buyer on the other end of that trade--and that he has thought things out as well...and you both cant be right. Granted, we both made money--but I submit that my trade was actually more of a gamble. I should have played the momentum more, and the idea that the warrants would be extended was truly a crapshoot. _______ In my previous post, one of the companies was Invivogen. Interesting catalog! invivogen.com I have to say, as I very slowly uncover just how vast is this topic of gene therapy...I am increasingly embarrassed by the fact that I happen to be the person who started this thread. Oh man, I am soooo lost, knowing a little of the jargon is such a poor excuse for speculating in this sector. Making money is a better excuse of course, but only after the fact.